News Brief: U. researchers test kidney cancer drug
Researchers at the School of Medicine and the Abramson Cancer Center will lead a nationwide trial of anti-cancer drug combinations in patients with advanced kidney cancer, according to a Penn Medicine press release. "This trial takes three proven drugs, and combines then into two drug combinations," Medicine Keith Flaherty said in a statement.





